Solara Active Pharma [SOLARAPP] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Solara Active Pharma Sciences Ltd.

BSE
Loading...

Sequent Scientific Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Solara Active Pharma Sciences Ltd. wins in 6 metrics, Sequent Scientific Ltd. wins in 13 metrics, with 0 ties. Sequent Scientific Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Solara Active Pharma Sciences Ltd. Sequent Scientific Ltd. Better
P/E Ratio (TTM) 2,428.57 123.42 Sequent Scientific Ltd.
Price-to-Book Ratio 1.25 6.21 Solara Active Pharma Sciences Ltd.
Debt-to-Equity Ratio 72.58 55.31 Sequent Scientific Ltd.
PEG Ratio -24.26 0.23 Sequent Scientific Ltd.
EV/EBITDA 10.57 30.04 Solara Active Pharma Sciences Ltd.
Profit Margin (TTM) 0.04% 2.52% Sequent Scientific Ltd.
Operating Margin (TTM) 7.72% 9.66% Sequent Scientific Ltd.
EBITDA Margin (TTM) 7.72% 9.66% Sequent Scientific Ltd.
Return on Equity 0.05% 6.64% Sequent Scientific Ltd.
Return on Assets (TTM) 2.92% 4.91% Sequent Scientific Ltd.
Free Cash Flow (TTM) $1.73B $442.73M Solara Active Pharma Sciences Ltd.
1-Year Return 22.59% 36.54% Sequent Scientific Ltd.
Price-to-Sales Ratio (TTM) 1.65 5.29 Solara Active Pharma Sciences Ltd.
Enterprise Value $21.80B $55.23B Sequent Scientific Ltd.
EV/Revenue Ratio 1.70 3.33 Solara Active Pharma Sciences Ltd.
Gross Profit Margin (TTM) 54.11% 54.46% Sequent Scientific Ltd.
Revenue per Share (TTM) $333 $66 Solara Active Pharma Sciences Ltd.
Earnings per Share (Diluted) $0.14 $1.63 Sequent Scientific Ltd.
Beta (Stock Volatility) 1.12 0.96 Sequent Scientific Ltd.

Solara Active Pharma Sciences Ltd. vs Sequent Scientific Ltd. Stock Performance Analysis

Loading Price Chart...

SOLARAPP
SEQUENT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Solara Active Pharma Sciences Ltd.-0.31%-3.50%-4.34%63.68%63.68%63.68%
Sequent Scientific Ltd.1.05%-2.04%19.71%22.01%15.29%17.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Solara Active Pharma Sciences Ltd.22.59%90.07%90.07%90.07%90.07%90.07%
Sequent Scientific Ltd.36.54%255.41%0.73%120.27%77.67%77.67%

Performance & Financial Health Analysis: Solara Active Pharma Sciences Ltd. vs Sequent Scientific Ltd.

MetricSOLARAPPSEQUENT
Market Information
Market Cap i₹21.12B₹84.41B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i578762,004
90 Day Avg. Volume i614791,567
Last Close₹446.85₹250.60
52 Week Range₹215.55 - ₹560.85₹166.00 - ₹277.35
% from 52W High-20.33%-9.64%
All-Time High₹560.85 (Dec 09, 2024)₹336.50 (Jun 28, 2021)
% from All-Time High-20.33%-25.53%
Growth Metrics
Quarterly Revenue Growth0.04%0.15%
Quarterly Earnings Growth-0.12%4.65%
Financial Health
Profit Margin (TTM) i0.00%0.03%
Operating Margin (TTM) i0.08%0.10%
Return on Equity (TTM) i0.00%0.07%
Debt to Equity (MRQ) i72.5855.31
Cash & Liquidity
Book Value per Share (MRQ)₹271.86₹32.38
Cash per Share (MRQ)₹1.02₹2.84
Operating Cash Flow (TTM) i₹2.13B₹1.04B
Levered Free Cash Flow (TTM) i₹-173,124,992₹-14,897,500
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Solara Active Pharma Sciences Ltd. vs Sequent Scientific Ltd.

MetricSOLARAPP (Aug 03, 2025)SEQUENT (Mar 28, 2026)
Price Ratios
P/E Ratio (TTM) i2,428.57123.42
Forward P/E iN/A39.84
PEG Ratio i-24.260.23
Price to Sales (TTM) i1.655.29
Price to Book (MRQ) i1.256.21
Market Capitalization
Market Capitalization i₹21.12B₹84.41B
Enterprise Value i₹21.80B₹55.23B
Enterprise Value Metrics
Enterprise to Revenue i1.703.33
Enterprise to EBITDA i10.5730.04
Risk & Other Metrics
Beta i1.120.96
Book Value per Share (MRQ) i₹271.86₹32.38

Financial Statements Comparison: Solara Active Pharma Sciences Ltd. vs Sequent Scientific Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSOLARAPP (2025)SEQUENT (2025)
Revenue/Sales i12.84B15.47B
Cost of Goods Sold i6.26B8.64B
COGS % of Revenue i48.8%55.9%
Gross Profit i6.57B6.83B
Gross Margin i51.2%44.1%
Research & Development iN/AN/A
Operating Income (EBIT) i1.07B1.19B
Operating Margin i8.3%7.7%
EBITDA i2.15B1.63B
EBITDA Margin i16.7%10.5%
Pre-Tax Income i5.40M443.06M
Pre-Tax Income % of Revenue i0.0%2.9%
Income Tax i0120.47M
Income Tax % of Revenue i0.0%0.8%
Net Income (Profit) i5.40M322.59M
Profit Margin i0.0%2.1%

Balance Sheet & Liquidity Metrics

MetricSOLARAPP (2025)SEQUENT (2025)
Cash & Equivalents i39.50M626.60M
Total Current Assets i7.29B8.74B
Total Current Assets % of Revenue i56.8%56.5%
Total Current Liabilities i9.44B5.05B
Total Current Liabilities % of Revenue i73.5%32.6%
Long-Term Debt i1.32B3.00B
Long-Term Debt % of Revenue i10.3%19.4%
Total Shareholders Equity i10.97B7.70B
Retained Earnings iN/A1.25B
Retained Earnings % of Revenue i0.0%8.1%
Property, Plant & Equipment i7.96B2.84B

Cash Flow Statement Comparison

MetricSOLARAPP (2025)SEQUENT (2025)
Operating Cash Flow i1.74B360.47M
Operating Cash Flow % of Revenue i13.6%2.3%
Capital Expenditures i3.80M-293.87M
Free Cash Flow i1.73B442.73M
FCF Margin i13.5%2.9%
Debt Repayment i-1.11B-1.88B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSOLARAPPSEQUENT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i48.05M435.72M
Float Shares i27.66M96.00M
% Held by Insiders i0.00%68.03%
% Held by Institutions i4.46%7.40%
% Held by Public i95.54%24.57%

Dividend Analysis & Yield Comparison: Solara Active Pharma Sciences Ltd. vs Sequent Scientific Ltd.

MetricSOLARAPPSEQUENT
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A